Natus Medical to Hold 2021 Third Quarter Financial Results Conference Call on November 5th
Natus Medical Incorporated (NASDAQ: NTUS) has announced that it will release its third quarter 2021 financial results on November 4, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Natus Medical Incorporated (NASDAQ: NTUS) has announced that it will release its third quarter 2021 financial results on November 4, after market close. A conference call is scheduled for November 5 at 8:00 a.m. ET to discuss the results and answer questions. Interested parties can access the call at 1-844-634-1441 domestically or 1-508-637-5658 internationally. A telephone replay will be available for 48 hours post-call, and the conference will also be streamed live online at Natus’s investor relations webpage.
Positive
- Scheduled release of Q3 2021 financial results indicates ongoing transparency with investors.
- Conference call offers opportunity for stakeholders to engage directly with management.
Negative
- None.
Details
News Market Reaction – NTUS
The recorded move for NTUS in the trading session of this news was -0.04%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PLEASANTON, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2021 third quarter financial results after the close of the market on Thursday, November 4th. Natus management will host a conference call on Friday, November 5th at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 3842689. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 3842689.
The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT:
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.